Skip to main content

Advertisement

SpringerLink
Log in

The relationship between lower urinary tract symptoms (LUTS), diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction in patients with moderate to severely symptomatic BPH

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the relationship between lower urinary tract symptoms (LUTS), different diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction (ED) in a selected group of BPH patients with moderate-or-severe symptoms, for whom either transurethral or open prostatectomy was planned.

Materials and methods

Between 2003 and 2006, 453 patients were included in this study. LUTS and ED were assessed by validated symptom scales. Maximum and average urine flow rates and post-void residual urine volumes (PVRU) of all patients were measured. Additionally, prostate volumes for all patients were detected with transrectal ultrasound (TRUS).

Results

The incidence of LUTS and ED increased significantly with aging (P < 0.001). ED was reported to be 36% in men with moderate LUTS and 94% in men with severe LUTS (P < 0.001). The odds ratio for ED was 28.7 for severe LUTS. When age, IPSS, and IIEF scores were analyzed we observed that the occurrence of LUTS is an age-independent risk factor for the development of ED (P < 0.001). There was a positive correlation between IIEF score, Q max (r = 0.441, P < 0.001), and Q ave (r = 0.326, P < 0.001), and a negative correlation was found between IIEF score, prostate volume (r = ­0.299, P < 0.001), and PVRU (r = ­0.486, P < 0.001).

Conclusions

The presence of LUTS, particularly severe LUTS, is an independent risk factor for ED. It is crucial to assess ED of the patient before BPH surgery, otherwise ED may be regarded as an outcome of the surgery rather than a preoperative, already existing condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Garraway WM, Collins GN, Lee RJ (1991) High prevalence of benign prostatic hypertrophy in the community. Lancet 338:469–471

    Article  PubMed  CAS  Google Scholar 

  2. Rosen R, Altwein J, Boyle P et al (2003) Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 44(6):637–649

    Article  PubMed  Google Scholar 

  3. Feldman HA, Goldstein I, Hatzichristou DG et al (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151(1):54–61

    PubMed  CAS  Google Scholar 

  4. DaSilva FC (1997) Benign prostatic hyperplasia: natural evolution versus medical treatment. Eur Urol 32(Suppl 2):34–37

    Google Scholar 

  5. Braun MH, Sommer F, Haupt G et al (2003) Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical “Aging Male” symptoms? Results of the “Cologne Male Survey”. Eur Urol 44(5):588–594

    Article  PubMed  CAS  Google Scholar 

  6. Boyle P, Robertson C, Mazzetta C et al (2003) The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study. BJU Int 92(7):719–725

    Article  PubMed  CAS  Google Scholar 

  7. Frankel SJ, Donovan JL, Peters TI et al (1998) Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol 51:677–685

    Article  PubMed  CAS  Google Scholar 

  8. Badia X, Garcia-Losa M, Dal-Re R (1997) Ten-language translation and harmonization of the International Prostate Symptom Score: developing a methodology for multinational clinical trials. Eur Urol 31(2):129–140

    PubMed  CAS  Google Scholar 

  9. Rosen RC, Cappelleri JC, Smith MD et al (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11:319–326

    Article  PubMed  CAS  Google Scholar 

  10. Cappelleri JC, Rosen RC, Smith MD et al (1999) Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 54(2):346–351

    Article  PubMed  CAS  Google Scholar 

  11. Elliott SP, Gulati M, Pasta DJ et al (2004) Obstructive lower urinary tract symptoms correlate with erectile dysfunction. Urology 63(6):1148–1152

    Article  PubMed  Google Scholar 

  12. Ponholzer A, Temml C, Obermayr R et al (2004) Association between lower urinary tract symptoms and erectile dysfunction. Urology 64(4):772–776

    Article  PubMed  Google Scholar 

  13. Blanker MH, Bohnen AM, Groeneveld FP et al (2001) Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study. J Am Geriatr Soc 49(4):436–442

    Article  PubMed  CAS  Google Scholar 

  14. Green JS, Holden ST, Bose P et al (2001) An investigation into the relationship between prostate size, peak urinary flow rate and male erectile dysfunction. Int J Impot Res 13(6):322–325

    Article  PubMed  CAS  Google Scholar 

  15. Schiff JD, Mulhall JP (2004) The link between LUTS and ED: clinical and basic science evidence. J Androl 25(4):470–478

    PubMed  Google Scholar 

  16. Sairam K, Kulinskaya E, McNicholas TA et al (2002) Sildenafil influences lower urinary tract symptoms. BJU Int 90(9):836–839

    Article  PubMed  CAS  Google Scholar 

  17. Khan MA, Dashwood MR, Thompson CS et al (1999) Upregulation of endothelin-B (ETB) receptors and ETB receptor-mediated rabbit detrusor contraction in partial bladder outlet obstruction. BJU Int 84(6):714–719

    Article  PubMed  CAS  Google Scholar 

  18. Mulhall JP, Guhring P, Parker M, Hopps C (2006) Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction. J Sex Med 3(4):662–667

    Article  PubMed  CAS  Google Scholar 

  19. McVary KT, Monnig W, Camps JL Jr, Young JM, Tseng LJ, van den Ende G (2007) Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 177(3):1071–1077

    Article  PubMed  CAS  Google Scholar 

  20. Kaplan SA, Gonzalez RR, Te AE (2007) Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction. Eur Urol 51(6):1717–1723

    Article  PubMed  CAS  Google Scholar 

  21. Andersson KE, Uckert S, Stief C, Hedlund P (2007) Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS. Neurourol Urodyn 26(Suppl.6):928–933

    Article  PubMed  CAS  Google Scholar 

  22. Kassabian VS (2003) Sexual function in patients treated for benign prostatic hyperplasia. Lancet 361(9351):60–62

    Article  PubMed  Google Scholar 

  23. Wasson JH, Reda DJ, Bruskewitz RC et al (1995) A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia: the Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 332:75–79

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of Ankara, School of Medicine, Ibni Sina Hastanesi, Samanpazari, Ankara, 06100, Turkey

    Asim Ozayar, Ali Ersin Zumrutbas & Onder Yaman

Authors
  1. Asim Ozayar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ali Ersin Zumrutbas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Onder Yaman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ali Ersin Zumrutbas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ozayar, A., Zumrutbas, A.E. & Yaman, O. The relationship between lower urinary tract symptoms (LUTS), diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction in patients with moderate to severely symptomatic BPH. Int Urol Nephrol 40, 933–939 (2008). https://doi.org/10.1007/s11255-008-9386-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-008-9386-z

Keywords

Search

Navigation